NDC 0143-9246 – Buprenorphine Hydrochloride
Buprenorphine Hydrochloride .324 mg/mL · Injection · Intramuscular, Intravenous
Product NDC0143-9246
Product details
- Brand name
- Buprenorphine Hydrochloride
- Generic name
- Buprenorphine Hydrochloride
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA076931
- Marketed since
- May 25, 2005
- Listing expires
- December 31, 2026
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine Hydrochloride .324 mg/mL
Uses, dosage, side effects and warnings for Buprenorphine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0143-9246-05 | 5 VIAL in 1 CARTON (0143-9246-05) / 1 mL in 1 VIAL (0143-9246-01) | Jul 12, 2019 |
Recalls mentioning this NDC
- D-1533-2020 Sep 2, 2020 · Class II
Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.
Other Buprenorphine Hydrochloride products
- 50090-7559 Buprenorphine Hydrochloride 8 mg/1 · Tablet · A-S Medication Solutions
- 72888-182 Buprenorphine Hydrochloride 2 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-183 Buprenorphine Hydrochloride 8 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-509 Buprenorphine Hydrochloride 4 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-510 Buprenorphine Hydrochloride 12 mg/1 · Tablet · Advagen Pharma Ltd
- 0409-2012 Buprenorphine Hydrochloride .3 mg/mL · Injection, Solution · Hospira, Inc.
- 0121-1019 Buprenorphine Hydrochloride 2 mg/1 · Tablet · PAI Holdings, LLC dba PAI Pharma
- 0121-2038 Buprenorphine Hydrochloride 8 mg/1 · Tablet · PAI Holdings, LLC dba PAI Pharma
- 42023-179 Buprenorphine Hydrochloride .324 mg/mL · Injection · Par Health USA, LLC
- 70518-4570 Buprenorphine Hydrochloride 2 mg/1 · Tablet · REMEDYREPACK INC.
- 70518-4571 Buprenorphine Hydrochloride 8 mg/1 · Tablet · REMEDYREPACK INC.
- 70069-027 Buprenorphine Hydrochloride .324 mg/mL · Injection · Somerset Therapeutics, LLC